Global Anti-tumor Drug Market Research Report 2024

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anti-tumor Drug Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Cytotoxic Drugs
1.2.3 Non-cytotoxic Drugs
1.3 Market by Application
1.3.1 Global Anti-tumor Drug Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Alkylating Agents
1.3.3 Anti-Metabolism Drugs
1.3.4 Platinum Antineoplastic Agents
1.3.5 Anthracycline Antitumor Drugs
1.3.6 Microtubule Stabilizer
1.3.7 Endocrine Therapy Drugs
1.3.8 Immunotherapy Drugs
1.3.9 Gene Therapy Drugs
1.3.10 Targeted Antineoplastic Drugs
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Anti-tumor Drug Market Perspective (2019-2030)
2.2 Anti-tumor Drug Growth Trends by Region
2.2.1 Global Anti-tumor Drug Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Anti-tumor Drug Historic Market Size by Region (2019-2024)
2.2.3 Anti-tumor Drug Forecasted Market Size by Region (2025-2030)
2.3 Anti-tumor Drug Market Dynamics
2.3.1 Anti-tumor Drug Industry Trends
2.3.2 Anti-tumor Drug Market Drivers
2.3.3 Anti-tumor Drug Market Challenges
2.3.4 Anti-tumor Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Anti-tumor Drug Players by Revenue
3.1.1 Global Top Anti-tumor Drug Players by Revenue (2019-2024)
3.1.2 Global Anti-tumor Drug Revenue Market Share by Players (2019-2024)
3.2 Global Anti-tumor Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Anti-tumor Drug Revenue
3.4 Global Anti-tumor Drug Market Concentration Ratio
3.4.1 Global Anti-tumor Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anti-tumor Drug Revenue in 2023
3.5 Anti-tumor Drug Key Players Head office and Area Served
3.6 Key Players Anti-tumor Drug Product Solution and Service
3.7 Date of Enter into Anti-tumor Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Anti-tumor Drug Breakdown Data by Type
4.1 Global Anti-tumor Drug Historic Market Size by Type (2019-2024)
4.2 Global Anti-tumor Drug Forecasted Market Size by Type (2025-2030)
5 Anti-tumor Drug Breakdown Data by Application
5.1 Global Anti-tumor Drug Historic Market Size by Application (2019-2024)
5.2 Global Anti-tumor Drug Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Anti-tumor Drug Market Size (2019-2030)
6.2 North America Anti-tumor Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Anti-tumor Drug Market Size by Country (2019-2024)
6.4 North America Anti-tumor Drug Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Anti-tumor Drug Market Size (2019-2030)
7.2 Europe Anti-tumor Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Anti-tumor Drug Market Size by Country (2019-2024)
7.4 Europe Anti-tumor Drug Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Anti-tumor Drug Market Size (2019-2030)
8.2 Asia-Pacific Anti-tumor Drug Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Anti-tumor Drug Market Size by Region (2019-2024)
8.4 Asia-Pacific Anti-tumor Drug Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Anti-tumor Drug Market Size (2019-2030)
9.2 Latin America Anti-tumor Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Anti-tumor Drug Market Size by Country (2019-2024)
9.4 Latin America Anti-tumor Drug Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Anti-tumor Drug Market Size (2019-2030)
10.2 Middle East & Africa Anti-tumor Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Anti-tumor Drug Market Size by Country (2019-2024)
10.4 Middle East & Africa Anti-tumor Drug Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Detail
11.1.2 Roche Business Overview
11.1.3 Roche Anti-tumor Drug Introduction
11.1.4 Roche Revenue in Anti-tumor Drug Business (2019-2024)
11.1.5 Roche Recent Development
11.2 Novartis
11.2.1 Novartis Company Detail
11.2.2 Novartis Business Overview
11.2.3 Novartis Anti-tumor Drug Introduction
11.2.4 Novartis Revenue in Anti-tumor Drug Business (2019-2024)
11.2.5 Novartis Recent Development
11.3 Celgene
11.3.1 Celgene Company Detail
11.3.2 Celgene Business Overview
11.3.3 Celgene Anti-tumor Drug Introduction
11.3.4 Celgene Revenue in Anti-tumor Drug Business (2019-2024)
11.3.5 Celgene Recent Development
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Company Detail
11.4.2 Bristol-Myers Squibb Business Overview
11.4.3 Bristol-Myers Squibb Anti-tumor Drug Introduction
11.4.4 Bristol-Myers Squibb Revenue in Anti-tumor Drug Business (2019-2024)
11.4.5 Bristol-Myers Squibb Recent Development
11.5 Amgen
11.5.1 Amgen Company Detail
11.5.2 Amgen Business Overview
11.5.3 Amgen Anti-tumor Drug Introduction
11.5.4 Amgen Revenue in Anti-tumor Drug Business (2019-2024)
11.5.5 Amgen Recent Development
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Detail
11.6.2 Johnson & Johnson Business Overview
11.6.3 Johnson & Johnson Anti-tumor Drug Introduction
11.6.4 Johnson & Johnson Revenue in Anti-tumor Drug Business (2019-2024)
11.6.5 Johnson & Johnson Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Detail
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Anti-tumor Drug Introduction
11.7.4 Pfizer Revenue in Anti-tumor Drug Business (2019-2024)
11.7.5 Pfizer Recent Development
11.8 Takeda
11.8.1 Takeda Company Detail
11.8.2 Takeda Business Overview
11.8.3 Takeda Anti-tumor Drug Introduction
11.8.4 Takeda Revenue in Anti-tumor Drug Business (2019-2024)
11.8.5 Takeda Recent Development
11.9 Eli Lilly
11.9.1 Eli Lilly Company Detail
11.9.2 Eli Lilly Business Overview
11.9.3 Eli Lilly Anti-tumor Drug Introduction
11.9.4 Eli Lilly Revenue in Anti-tumor Drug Business (2019-2024)
11.9.5 Eli Lilly Recent Development
11.10 AstraZeneca
11.10.1 AstraZeneca Company Detail
11.10.2 AstraZeneca Business Overview
11.10.3 AstraZeneca Anti-tumor Drug Introduction
11.10.4 AstraZeneca Revenue in Anti-tumor Drug Business (2019-2024)
11.10.5 AstraZeneca Recent Development
11.11 Astellas
11.11.1 Astellas Company Detail
11.11.2 Astellas Business Overview
11.11.3 Astellas Anti-tumor Drug Introduction
11.11.4 Astellas Revenue in Anti-tumor Drug Business (2019-2024)
11.11.5 Astellas Recent Development
11.12 Merck & Co
11.12.1 Merck & Co Company Detail
11.12.2 Merck & Co Business Overview
11.12.3 Merck & Co Anti-tumor Drug Introduction
11.12.4 Merck & Co Revenue in Anti-tumor Drug Business (2019-2024)
11.12.5 Merck & Co Recent Development
11.13 Sanofi
11.13.1 Sanofi Company Detail
11.13.2 Sanofi Business Overview
11.13.3 Sanofi Anti-tumor Drug Introduction
11.13.4 Sanofi Revenue in Anti-tumor Drug Business (2019-2024)
11.13.5 Sanofi Recent Development
11.14 Bayer
11.14.1 Bayer Company Detail
11.14.2 Bayer Business Overview
11.14.3 Bayer Anti-tumor Drug Introduction
11.14.4 Bayer Revenue in Anti-tumor Drug Business (2019-2024)
11.14.5 Bayer Recent Development
11.15 Biogen Idec
11.15.1 Biogen Idec Company Detail
11.15.2 Biogen Idec Business Overview
11.15.3 Biogen Idec Anti-tumor Drug Introduction
11.15.4 Biogen Idec Revenue in Anti-tumor Drug Business (2019-2024)
11.15.5 Biogen Idec Recent Development
11.16 Eisai
11.16.1 Eisai Company Detail
11.16.2 Eisai Business Overview
11.16.3 Eisai Anti-tumor Drug Introduction
11.16.4 Eisai Revenue in Anti-tumor Drug Business (2019-2024)
11.16.5 Eisai Recent Development
11.17 Teva
11.17.1 Teva Company Detail
11.17.2 Teva Business Overview
11.17.3 Teva Anti-tumor Drug Introduction
11.17.4 Teva Revenue in Anti-tumor Drug Business (2019-2024)
11.17.5 Teva Recent Development
11.18 Otsuka
11.18.1 Otsuka Company Detail
11.18.2 Otsuka Business Overview
11.18.3 Otsuka Anti-tumor Drug Introduction
11.18.4 Otsuka Revenue in Anti-tumor Drug Business (2019-2024)
11.18.5 Otsuka Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Anti-tumor Drug Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Cytotoxic Drugs
Table 3. Key Players of Non-cytotoxic Drugs
Table 4. Global Anti-tumor Drug Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Anti-tumor Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Anti-tumor Drug Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Anti-tumor Drug Market Share by Region (2019-2024)
Table 8. Global Anti-tumor Drug Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Anti-tumor Drug Market Share by Region (2025-2030)
Table 10. Anti-tumor Drug Market Trends
Table 11. Anti-tumor Drug Market Drivers
Table 12. Anti-tumor Drug Market Challenges
Table 13. Anti-tumor Drug Market Restraints
Table 14. Global Anti-tumor Drug Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Anti-tumor Drug Market Share by Players (2019-2024)
Table 16. Global Top Anti-tumor Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-tumor Drug as of 2023)
Table 17. Ranking of Global Top Anti-tumor Drug Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Anti-tumor Drug Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Anti-tumor Drug Product Solution and Service
Table 21. Date of Enter into Anti-tumor Drug Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Anti-tumor Drug Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Anti-tumor Drug Revenue Market Share by Type (2019-2024)
Table 25. Global Anti-tumor Drug Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Anti-tumor Drug Revenue Market Share by Type (2025-2030)
Table 27. Global Anti-tumor Drug Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Anti-tumor Drug Revenue Market Share by Application (2019-2024)
Table 29. Global Anti-tumor Drug Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Anti-tumor Drug Revenue Market Share by Application (2025-2030)
Table 31. North America Anti-tumor Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Anti-tumor Drug Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Anti-tumor Drug Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Anti-tumor Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Anti-tumor Drug Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Anti-tumor Drug Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Anti-tumor Drug Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Anti-tumor Drug Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Anti-tumor Drug Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Anti-tumor Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Anti-tumor Drug Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Anti-tumor Drug Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Anti-tumor Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Anti-tumor Drug Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Anti-tumor Drug Market Size by Country (2025-2030) & (US$ Million)
Table 46. Roche Company Detail
Table 47. Roche Business Overview
Table 48. Roche Anti-tumor Drug Product
Table 49. Roche Revenue in Anti-tumor Drug Business (2019-2024) & (US$ Million)
Table 50. Roche Recent Development
Table 51. Novartis Company Detail
Table 52. Novartis Business Overview
Table 53. Novartis Anti-tumor Drug Product
Table 54. Novartis Revenue in Anti-tumor Drug Business (2019-2024) & (US$ Million)
Table 55. Novartis Recent Development
Table 56. Celgene Company Detail
Table 57. Celgene Business Overview
Table 58. Celgene Anti-tumor Drug Product
Table 59. Celgene Revenue in Anti-tumor Drug Business (2019-2024) & (US$ Million)
Table 60. Celgene Recent Development
Table 61. Bristol-Myers Squibb Company Detail
Table 62. Bristol-Myers Squibb Business Overview
Table 63. Bristol-Myers Squibb Anti-tumor Drug Product
Table 64. Bristol-Myers Squibb Revenue in Anti-tumor Drug Business (2019-2024) & (US$ Million)
Table 65. Bristol-Myers Squibb Recent Development
Table 66. Amgen Company Detail
Table 67. Amgen Business Overview
Table 68. Amgen Anti-tumor Drug Product
Table 69. Amgen Revenue in Anti-tumor Drug Business (2019-2024) & (US$ Million)
Table 70. Amgen Recent Development
Table 71. Johnson & Johnson Company Detail
Table 72. Johnson & Johnson Business Overview
Table 73. Johnson & Johnson Anti-tumor Drug Product
Table 74. Johnson & Johnson Revenue in Anti-tumor Drug Business (2019-2024) & (US$ Million)
Table 75. Johnson & Johnson Recent Development
Table 76. Pfizer Company Detail
Table 77. Pfizer Business Overview
Table 78. Pfizer Anti-tumor Drug Product
Table 79. Pfizer Revenue in Anti-tumor Drug Business (2019-2024) & (US$ Million)
Table 80. Pfizer Recent Development
Table 81. Takeda Company Detail
Table 82. Takeda Business Overview
Table 83. Takeda Anti-tumor Drug Product
Table 84. Takeda Revenue in Anti-tumor Drug Business (2019-2024) & (US$ Million)
Table 85. Takeda Recent Development
Table 86. Eli Lilly Company Detail
Table 87. Eli Lilly Business Overview
Table 88. Eli Lilly Anti-tumor Drug Product
Table 89. Eli Lilly Revenue in Anti-tumor Drug Business (2019-2024) & (US$ Million)
Table 90. Eli Lilly Recent Development
Table 91. AstraZeneca Company Detail
Table 92. AstraZeneca Business Overview
Table 93. AstraZeneca Anti-tumor Drug Product
Table 94. AstraZeneca Revenue in Anti-tumor Drug Business (2019-2024) & (US$ Million)
Table 95. AstraZeneca Recent Development
Table 96. Astellas Company Detail
Table 97. Astellas Business Overview
Table 98. Astellas Anti-tumor Drug Product
Table 99. Astellas Revenue in Anti-tumor Drug Business (2019-2024) & (US$ Million)
Table 100. Astellas Recent Development
Table 101. Merck & Co Company Detail
Table 102. Merck & Co Business Overview
Table 103. Merck & Co Anti-tumor Drug Product
Table 104. Merck & Co Revenue in Anti-tumor Drug Business (2019-2024) & (US$ Million)
Table 105. Merck & Co Recent Development
Table 106. Sanofi Company Detail
Table 107. Sanofi Business Overview
Table 108. Sanofi Anti-tumor Drug Product
Table 109. Sanofi Revenue in Anti-tumor Drug Business (2019-2024) & (US$ Million)
Table 110. Sanofi Recent Development
Table 111. Bayer Company Detail
Table 112. Bayer Business Overview
Table 113. Bayer Anti-tumor Drug Product
Table 114. Bayer Revenue in Anti-tumor Drug Business (2019-2024) & (US$ Million)
Table 115. Bayer Recent Development
Table 116. Biogen Idec Company Detail
Table 117. Biogen Idec Business Overview
Table 118. Biogen Idec Anti-tumor Drug Product
Table 119. Biogen Idec Revenue in Anti-tumor Drug Business (2019-2024) & (US$ Million)
Table 120. Biogen Idec Recent Development
Table 121. Eisai Company Detail
Table 122. Eisai Business Overview
Table 123. Eisai Anti-tumor Drug Product
Table 124. Eisai Revenue in Anti-tumor Drug Business (2019-2024) & (US$ Million)
Table 125. Eisai Recent Development
Table 126. Teva Company Detail
Table 127. Teva Business Overview
Table 128. Teva Anti-tumor Drug Product
Table 129. Teva Revenue in Anti-tumor Drug Business (2019-2024) & (US$ Million)
Table 130. Teva Recent Development
Table 131. Otsuka Company Detail
Table 132. Otsuka Business Overview
Table 133. Otsuka Anti-tumor Drug Product
Table 134. Otsuka Revenue in Anti-tumor Drug Business (2019-2024) & (US$ Million)
Table 135. Otsuka Recent Development
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Anti-tumor Drug Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Anti-tumor Drug Market Share by Type: 2023 VS 2030
Figure 3. Cytotoxic Drugs Features
Figure 4. Non-cytotoxic Drugs Features
Figure 5. Global Anti-tumor Drug Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Anti-tumor Drug Market Share by Application: 2023 VS 2030
Figure 7. Alkylating Agents Case Studies
Figure 8. Anti-Metabolism Drugs Case Studies
Figure 9. Platinum Antineoplastic Agents Case Studies
Figure 10. Anthracycline Antitumor Drugs Case Studies
Figure 11. Microtubule Stabilizer Case Studies
Figure 12. Endocrine Therapy Drugs Case Studies
Figure 13. Immunotherapy Drugs Case Studies
Figure 14. Gene Therapy Drugs Case Studies
Figure 15. Targeted Antineoplastic Drugs Case Studies
Figure 16. Anti-tumor Drug Report Years Considered
Figure 17. Global Anti-tumor Drug Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 18. Global Anti-tumor Drug Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 19. Global Anti-tumor Drug Market Share by Region: 2023 VS 2030
Figure 20. Global Anti-tumor Drug Market Share by Players in 2023
Figure 21. Global Top Anti-tumor Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-tumor Drug as of 2023)
Figure 22. The Top 10 and 5 Players Market Share by Anti-tumor Drug Revenue in 2023
Figure 23. North America Anti-tumor Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. North America Anti-tumor Drug Market Share by Country (2019-2030)
Figure 25. United States Anti-tumor Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Canada Anti-tumor Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Europe Anti-tumor Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Europe Anti-tumor Drug Market Share by Country (2019-2030)
Figure 29. Germany Anti-tumor Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. France Anti-tumor Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. U.K. Anti-tumor Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Italy Anti-tumor Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Russia Anti-tumor Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Nordic Countries Anti-tumor Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Asia-Pacific Anti-tumor Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Asia-Pacific Anti-tumor Drug Market Share by Region (2019-2030)
Figure 37. China Anti-tumor Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Japan Anti-tumor Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. South Korea Anti-tumor Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Southeast Asia Anti-tumor Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. India Anti-tumor Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Australia Anti-tumor Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Latin America Anti-tumor Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Latin America Anti-tumor Drug Market Share by Country (2019-2030)
Figure 45. Mexico Anti-tumor Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Brazil Anti-tumor Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Anti-tumor Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Anti-tumor Drug Market Share by Country (2019-2030)
Figure 49. Turkey Anti-tumor Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. Saudi Arabia Anti-tumor Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 51. Roche Revenue Growth Rate in Anti-tumor Drug Business (2019-2024)
Figure 52. Novartis Revenue Growth Rate in Anti-tumor Drug Business (2019-2024)
Figure 53. Celgene Revenue Growth Rate in Anti-tumor Drug Business (2019-2024)
Figure 54. Bristol-Myers Squibb Revenue Growth Rate in Anti-tumor Drug Business (2019-2024)
Figure 55. Amgen Revenue Growth Rate in Anti-tumor Drug Business (2019-2024)
Figure 56. Johnson & Johnson Revenue Growth Rate in Anti-tumor Drug Business (2019-2024)
Figure 57. Pfizer Revenue Growth Rate in Anti-tumor Drug Business (2019-2024)
Figure 58. Takeda Revenue Growth Rate in Anti-tumor Drug Business (2019-2024)
Figure 59. Eli Lilly Revenue Growth Rate in Anti-tumor Drug Business (2019-2024)
Figure 60. AstraZeneca Revenue Growth Rate in Anti-tumor Drug Business (2019-2024)
Figure 61. Astellas Revenue Growth Rate in Anti-tumor Drug Business (2019-2024)
Figure 62. Merck & Co Revenue Growth Rate in Anti-tumor Drug Business (2019-2024)
Figure 63. Sanofi Revenue Growth Rate in Anti-tumor Drug Business (2019-2024)
Figure 64. Bayer Revenue Growth Rate in Anti-tumor Drug Business (2019-2024)
Figure 65. Biogen Idec Revenue Growth Rate in Anti-tumor Drug Business (2019-2024)
Figure 66. Eisai Revenue Growth Rate in Anti-tumor Drug Business (2019-2024)
Figure 67. Teva Revenue Growth Rate in Anti-tumor Drug Business (2019-2024)
Figure 68. Otsuka Revenue Growth Rate in Anti-tumor Drug Business (2019-2024)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

Your Name

Your E-mail

Your message

Submit